Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility
Background Several new genes and clinical subtypes have been identified since the
publication in 2014 of the report of the last International Consensus Meeting on …
publication in 2014 of the report of the last International Consensus Meeting on …
Epidermolysis bullosa: Molecular pathology of connective tissue components in the cutaneous basement membrane zone
C Has, A Nyström, AH Saeidian, L Bruckner-Tuderman… - Matrix Biology, 2018 - Elsevier
Epidermolysis bullosa (EB), a group of heritable skin fragility disorders, is characterized by
blistering, erosions and chronic ulcers in the skin and mucous membranes. In some forms …
blistering, erosions and chronic ulcers in the skin and mucous membranes. In some forms …
Clinical practice guidelines for laboratory diagnosis of epidermolysis bullosa
C Has, L Liu, MC Bolling… - The British journal …, 2019 - pmc.ncbi.nlm.nih.gov
Clinical practice guidelines for laboratory diagnosis of epidermolysis bullosa - PMC Skip to main
content Here's how you know Official websites use .gov A .gov website belongs to an official …
content Here's how you know Official websites use .gov A .gov website belongs to an official …
Inherited epidermolysis bullosa: new diagnostics and new clinical phenotypes
Inherited epidermolysis bullosa (EB) is a group of heterogeneous genetic disorders
characterized by skin fragility. EB comprises a large spectrum of phenotypes, ranging from …
characterized by skin fragility. EB comprises a large spectrum of phenotypes, ranging from …
[HTML][HTML] EB2017—progress in epidermolysis bullosa research toward treatment and cure
J Uitto, L Bruckner-Tuderman, JA McGrath… - Journal of Investigative …, 2018 - Elsevier
Epidermolysis bullosa, a group of heritable blistering disorders, shows extensive phenotypic
variability due to mutations in as many as 20 distinct genes. There is no cure for this …
variability due to mutations in as many as 20 distinct genes. There is no cure for this …
A decade of next‐generation sequencing in genodermatoses: the impact on gene discovery and clinical diagnostics
FPC Chiu, BJ Doolan, JA McGrath… - British Journal of …, 2021 - academic.oup.com
Background Discovering the genetic basis of inherited skin diseases is fundamental to
improving diagnostic accuracy and genetic counselling. In the 1990s and 2000s, genetic …
improving diagnostic accuracy and genetic counselling. In the 1990s and 2000s, genetic …
Stairways to advanced therapies for epidermolysis bullosa
L De Rosa, E Enzo, M Palamenghi… - Cold Spring …, 2023 - cshperspectives.cshlp.org
Epidermolysis bullosa (EB) is a devastating genetic skin disease typified by a plethora of
different phenotypes and ranking from severe, early lethal, to mild localized forms. Although …
different phenotypes and ranking from severe, early lethal, to mild localized forms. Although …
Mouse models for dominant dystrophic epidermolysis bullosa carrying common human point mutations recapitulate the human disease
BRC Smith, A Nyström, CJ Nowell… - Disease models & …, 2021 - journals.biologists.com
Heterozygous missense mutations in the human COL7A1 gene–coding for collagen VII–
lead to the rare, dominantly inherited skin disorder dominant dystrophic epidermolysis …
lead to the rare, dominantly inherited skin disorder dominant dystrophic epidermolysis …
Integrated Management Strategies for Epidermolysis Bullosa: Current Insights
H Sait, S Srivastava, D Saxena - International Journal of General …, 2022 - Taylor & Francis
Epidermolysis bullosa (EB) is a group of rare genodermatoses that is characterized by skin
fragility resulting from minor trauma. There are four major subtypes, namely, EB simplex …
fragility resulting from minor trauma. There are four major subtypes, namely, EB simplex …
Dystrophic epidermolysis bullosa: genotype-phenotype correlations
AA Kubanov, VV Chikin - Vestnik dermatologii i venerologii, 2023 - vestnikdv.ru
Dystrophic epidermolysis bullosa is caused by mutations in the COL7A1 gene. The disease
characterized by clinical heterogeneity. To date, scientific findings allow to evaluate …
characterized by clinical heterogeneity. To date, scientific findings allow to evaluate …